<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M479</article-id>
      <article-id pub-id-type="publisher-id">molbank-2006-M479</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis of 1-[3-(2-methyl-5-nitro-<italic>1H</italic>-imidazol-1-yl)propyl]-<italic>1H</italic>-1,2,3-benzotriazole and 1-[3-(2-methyl-5-nitro-<italic>1H</italic>-imidazol-1-yl)butyl]-<italic>1H</italic>-1,2,3-benzotriazole</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nowak</surname>
            <given-names>Krystyna</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grzego&#x17C;ek</surname>
            <given-names>Maria</given-names>
          </name>
          <xref rid="c1-molbank-2006-M479" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Szpakiewicz</surname>
            <given-names>Barbara</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2006-M479">Institute of Organic Chemistry and Technology, Cracow University of Technology, ul. Warszawska 24, PL-31155 Krak&#xF3;w, Poland, Tel/Fax (048-12) 628-20-37 e-mail: <underline><email>magre@indy.chemia.pk.edu.pl</email></underline></aff>
	  <author-notes>
        <corresp id="c1-molbank-2006-M479"><label>*</label>Author to whom correspondence should be addressed</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>03</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>03</month>
        <year>2006</year>
      </pub-date>
      <volume>2006</volume>
      <issue>3</issue>
      <elocation-id>M479</elocation-id>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>10</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>10</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2006 <underline>MDPI</underline>.</copyright-statement>
        <copyright-year>2006</copyright-year>
        <license>
          <p>All rights reserved.</p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>1,2,3-benzotriazole derivatives</kwd>
		<kwd>2-methyl-5-nitroimidazole derivatives</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
  <p><disp-formula><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M479-i001.tif"/></disp-formula></p>
      <p>The title compounds were obtained in reaction 1,2,3-benzotriazole (<bold>1</bold>) with 1-(3-chloropropyl)- (<bold>2a</bold>) and 1-(4-bromobutyl)-2-methyl-5-nitro-<italic>1H</italic>-imidazole (<bold>2b</bold>) [<xref ref-type="bibr" rid="B1-molbank-2006-M479">1</xref>].</p>
      <p>The derivatives of 5-nitroimidazole show various interesting biological properties. They have good chemotherapeutic activity [<xref ref-type="bibr" rid="B2-molbank-2006-M479">2</xref>], are potent anti-bacterial agents [<xref ref-type="bibr" rid="B2-molbank-2006-M479">2</xref>] and are very effective against various infections especially antiprotozoic [<xref ref-type="bibr" rid="B3-molbank-2006-M479">3</xref>].</p>
      <p><bold>1-[3-(2-methyl-5-nitro-<italic>1H</italic>-imidazol-1-yl)propyl]- <italic>1H</italic>-1,2,3-benzotriazole (3a)</bold></p>
      <p>A mixture of 1,2,3-benzotriazole (<bold>1</bold>) (commercial product) (0.76 g, 6.38 mmol), 1-(3-chloro- propyl)-2-methyl-5-nitro-<italic>1H</italic>-imidazole (1.58 g, 7.76 mmol) (<bold>2a</bold>) [<xref ref-type="bibr" rid="B1-molbank-2006-M479">1</xref>] and powdered anhydrous K<sub>2</sub>CO<sub>3</sub> (2 g) and a catalytic amount of KI in dry DMF (25 mL) was stirred at room temperature for 24 h. The resulting solution was poured into water (100 mL) and precipitated solid was filtered off and washed with water. The crude product was purified by recrystallization from isopropyl alcohol giving 1-[3-(2-methyl-5-nitro-<italic>1H</italic>-imidazol-1-yl) propyl]-<italic>1H</italic>-1,2,3-benzotriazole (<bold>3a</bold>) as colorless needles (1.45 g,  79.5%).</p>
      <p>Melting point: 167-169&#xB0;C</p>
      <p><sup>1</sup>H-NMR (CDCl<sub>3</sub>, 80 MHz ): &#x3B4;= 8.10 (dd, 1H, aromatic H, <italic>J</italic> = 8.96 Hz , <italic>J</italic> = 1.21 Hz), 7.80 (s, 1H, CH imid.), 7.32-7.57 (m, 3H, aromatic H), 4.70 (t, 2H, CH<italic><sub>2</sub></italic><sub>&#xAD;</sub> <italic>CH<sub>2</sub></italic>-N-benzotriazole, <italic>J</italic> = 6.40 Hz), 4.04 (t, 2H, CH<italic><sub>2</sub></italic><sub>&#xAD;</sub> <italic>CH<sub>2</sub></italic>-N-imid., <italic>J</italic> = 7.12 Hz), 2.66-2.35 (m, 2H, CH<sub>2</sub> <italic>CH<sub>2</sub></italic><sub>&#xAD;</sub> CH<sub>2</sub> ), 2.34 (s, 3H, CH<sub>3</sub>),</p>
      <p>MS, (70eV) m/z (%): 286 (7.0), 269 (5.0), 171 (100).</p>
      <p>IR (KBr, cm<sup>-1</sup>): 1537 and 1336 (NO<sub>2</sub>), 1495 (CH<sub>2</sub>), 1292 (C-N).</p>
      <p>Elemental Analysis: Calculated for C<sub>13</sub>H<sub>14</sub>N<sub>6</sub>O<sub>2</sub> (286.29): C 54.54, H 4.93, N 29.36; found C 54.23, H 4.87, N 29.02.</p>
      <p><bold>1-[3-(2-methyl-5-nitro-<italic>1H</italic>-imidazol-1-yl)butyl]-<italic>1H</italic>-1,2,3-benzotriazole (3b)</bold></p>
      <p>A mixture of 1,2,3-benzotriazole (<bold>1</bold>) (commercial product) (0.38 g, 3.19 mmol), 1-(3-bromo- butyl)-2-methyl-5-nitro-<italic>1H</italic>-imidazole (0.85 g, 3.43 mmol) (<bold>2b</bold>) [<xref ref-type="bibr" rid="B1-molbank-2006-M479">1</xref>] and powdered anhydrous K<sub>2</sub>CO<sub>3</sub> (0.65 g) and a catalytic amount of KI in dry DMF (20 mL) was stirred at room temperature for 19 h. The resultating solution was poured into water (60 mL) and precipitated solid was filtered off, and washed with water. The crude product was purified by recrystallization from isopropyl alcohol giving 1-[3-(2-methyl-5-nitro-<italic>1H</italic>-imidazol-1-yl) butyl]-1H-1,2,3-benzotriazole (<bold>3b</bold>) as colourless needles (0.72 g,  75.2%).</p>
      <p>Melting point: 168-170&#xB0;C</p>
      <p><sup>1</sup>H NMR (CDCl<sub>3</sub>, 80 MHz ): &#x3B4;= 7.93-7.34 (m, 4H, aromatic H), 7.66 (s, 1H, CH imid.), 4.81 (t, 2H, CH<italic><sub>2</sub></italic><sub>&#xAD;</sub> <italic>CH<sub>2</sub></italic>-N-benzotriazole, <italic>J</italic> = 6.32 Hz), 3.91 (t, 2H, CH<italic><sub>2</sub></italic><sub>&#xAD;</sub> <italic>CH<sub>2</sub></italic>-N-imid., <italic>J</italic> = 7.36 Hz ), 2.43-1.71 (m, 4H, CH<sub>2</sub> <italic>CH<sub>2</sub></italic><sub>&#xAD;</sub> <italic>CH<sub>2</sub></italic>CH<sub>2</sub> ), 2.37 (s, 3H, CH<sub>3</sub>).</p>
      <p>IR (KBr, cm<sup>-1</sup>): 1539 and 1330 (NO<sub>2</sub>), 1496 (CH<sub>2</sub>) 1289 (C-N).</p>
      <p>Elemental Analysis: Calculated C<sub>14</sub>H<sub>16</sub>N<sub>6</sub>O<sub>2</sub> (300.32): C 55.99, H 5.37, N 27.98; found C 55.82, H 5.36, N 27.84.</p>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2006-M479">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2006-M479-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M479-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2006-M479-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M479-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
        <supplementary-material id="molbank-2006-M479-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M479-s002-mod.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
        <supplementary-material id="molbank-2006-M479-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2006-M479-s002.mol">
   <label>Supplementary File 4</label>
</supplementary-material>
    </app>
</app-group>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2006-M479">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourdais</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Bull. Soc. Chim.</source>
          <year>1968</year>
          <fpage>3246</fpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2006-M479">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhaumik</surname>
              <given-names>K.</given-names>
            </name>
			 <name>
              <surname>Akamanchi</surname>
              <given-names>K.G.</given-names>
            </name>
          </person-group>
          <source>J. Heterocyclic Chem.</source>
          <year>2004</year>
          <volume>41</volume>
          <fpage>51</fpage>
        </citation>
      </ref>
      <ref id="B3-molbank-2006-M479">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silvestri</surname>
              <given-names>R.</given-names>
            </name>
			<name>
              <surname>Artico</surname>
              <given-names>M.</given-names>
            </name>
			<name>
              <surname>Massa</surname>
              <given-names>S.</given-names>
            </name>
			<name>
              <surname>Marceddu</surname>
              <given-names>T.</given-names>
            </name>
			<name>
              <surname>de Montis</surname>
              <given-names>F.</given-names>
            </name>
			<name>
              <surname>La Colla</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <source>Bioorg. Med. Chem.</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>253</fpage>
        </citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn>
        <p><italic>Sample Availability</italic>: Available from MDPI.</p>
      </fn>
    </fn-group>
  </back>
</article>
